Skip to main content
Equibles

Laurie Smaldone Alsup

CEO

Theravance Biopharma, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Laurie Smaldone Alsup

Laurie Smaldone Alsup is recorded as CEO at Theravance Biopharma, Inc.. Theravance Biopharma, Inc. reported in an 8-K filed September 23, 2026 that Laurie Smaldone Alsup resigned as Board of Directors, effective September 23, 2026.

“at the Effective Time, each of Rick E Winningham, Laurie Smaldone Alsup, Susannah Gray, Dean J. Mitchell, Donal O’Connor and Deepa R. Pakianathan resigned from the Company’s Board of Directors”
Theravance Biopharma, Inc. Form 8-K, filed September 23, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Theravance Biopharma, Inc.

    CEO

    Proxy statement

    Current

    Start not stated–present

  • Theravance Biopharma, Inc.

    Board Member

    Proxy statement

    Start not stated–2026-09-23

Company network

Recorded roles and call appearances connecting this person to public companies.

Theravance Biopharma, Inc.

Current role

CEO

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.